补肾强骨汤对54例骨质疏松症患者骨密度和生活质量的影响

Effect of Bushen Qianggu decoction on bone mineral density and quality of life in the treatment of 54 patients with osteoporosis

目的 :探讨补肾强骨汤对骨质疏松症患者骨密度和生活质量的影响。方法 :选取骨质疏松患者108例随机分为观察组和对照组各54例,对照组给予口服钙尔奇D治疗,观察组在此基础上给予补肾强骨汤治疗,采用酶联免疫吸附法(ELISA)检测血清骨钙素(BGP)、碱性磷酸酶(ALP)、尿脱氧吡啶酚(DPD),采用健康调查简表(SF-36)评估生活质量,统计分析所有患者临床疗效、治疗前后骨代谢因子水平、骨密度(腰椎L1~4、大粗隆)和生活质量及不良反应情况。结果 :观察组患者治疗有效率、血清BGP、ALP、DPD水平,以及腰椎L1~4、大粗隆骨密度和SF-36各项得分明显优于对照组(P<0.05),且两组患者治疗期间均无明显不良反应发生。结论 :补肾强骨汤治疗可有效提高骨质疏松患者疗效,改善患者骨代谢和提高患者骨密度,有利于改善患者的生活质量,且具有良好的安全性。

Objective： To discuss the effect of Bushen Qianggu decoction on bone mineral density and quality of life in the treatment of patients with osteoporosis. Methods： One hundred and eight patients with osteoporosis were selected and randomly divided into a control group（received oral caltrate D） and an observation group（received Bushen Qianggu decoction besides caltrate D） with 54 cases each. Serum bone gamma-carboxyglutamic-acid-containing proteins（BGP）, alkaline phosphatase（ALP） and deoxypyridinoline（DPD） were detected by ELISA, and the quality of life was assessed by health survey profiles（SF-36）. Clinical curative effect, the levels of bone metabolic factors, bone density（lumbar L1~4, great tuberosity）, life quality and adverse reactions before and after the treatment were analyzed. Results： Treatment efficiency, serum BGP, ALP, DPD levels as well as scores of lumbar L1~4, great tuberosity and SF-36 were all significantly better in the observation group than in the control group（P〈0.05）. There were no significant adverse reactions occurred in both groups. Conclusion： Bushen Qianggu decoction can enhance the curative effect of patients with osteoporosis, improve bone metabolism, bone mineral density and the quality of life with good safety.